BioVie (BIVI) Stock Chart & Stock Price History → Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (From InvestorPlace) (Ad) Free BIVI Stock Alerts $0.46 +0.02 (+4.59%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BioVie Stock Price Performance5 Day Performance+0.29%1 Month Performance-7.61%3 Month Performance-75.90%6 Month Performance-72.89%Year-To-Date Performance-63.85%1 Year Performance-92.43% Receive BIVI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. BIVI Stock Chart for Sunday, June, 2, 2024 BIVI Chart by TradingView BioVie Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.44$0.46+3.52%$0.46$0.44374,588 shs$27.80 million05/30/2024$0.44$0.44+0.59%$0.45$0.43367,554 shs$26.85 million05/29/2024$0.45$0.44-3.12%$0.45$0.42435,965 shs$26.69 million05/28/2024$0.45$0.45-0.59%$0.46$0.43787,191 shs$27.55 million05/27/2024$0.45$0.45$0.47$0.44857,900 shs$27.72 million05/24/2024$0.46$0.45-1.26%$0.47$0.44844,738 shs$27.72 million Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.48$0.46-5.00%$0.48$0.46470,146 shs$18.36 million05/22/2024$0.48$0.48+0.10%$0.48$0.47750,020 shs$19.33 million05/21/2024$0.47$0.48+2.67%$0.49$0.47355,105 shs$19.31 million05/20/2024$0.49$0.47-4.21%$0.49$0.46665,593 shs$18.81 million05/17/2024$0.50$0.49-1.42%$0.50$0.49218,344 shs$19.63 million05/16/2024$0.49$0.50+0.81%$0.51$0.48545,818 shs$19.92 million05/15/2024$0.50$0.49-0.82%$0.50$0.48384,391 shs$19.76 million05/14/2024$0.48$0.50+3.42%$0.51$0.48428,051 shs$19.92 million05/13/2024$0.49$0.48-0.76%$0.50$0.48188,179 shs$19.26 million05/10/2024$0.50$0.49-2.25%$0.50$0.49202,349 shs$19.41 million05/09/2024$0.49$0.50+2.49%$0.50$0.48138,148 shs$19.86 million05/08/2024$0.49$0.49-0.45%$0.49$0.48155,408 shs$19.37 million05/07/2024$0.49$0.49+0.23%$0.50$0.48151,756 shs$19.46 million05/06/2024$0.49$0.49-0.82%$0.51$0.48345,860 shs$19.42 million05/03/2024$0.50$0.49-1.90%$0.51$0.49411,212 shs$19.58 million05/02/2024$0.49$0.50+1.40%$0.50$0.48216,294 shs$19.96 million05/01/2024$0.49$0.49+0.61%$0.50$0.48544,015 shs$19.68 million04/30/2024$0.50$0.49-1.01%$0.51$0.49496,066 shs$19.56 million04/29/2024$0.48$0.50+2.10%$0.51$0.491.13 million shs$19.76 million04/26/2024$0.49$0.48-0.84%$0.50$0.48315,492 shs$19.35 million04/25/2024$0.51$0.49-3.26%$0.51$0.47778,051 shs$19.52 million04/24/2024$0.49$0.51+2.77%$0.52$0.48851,873 shs$20.18 million04/23/2024$0.48$0.49+1.78%$0.52$0.47686,715 shs$19.63 million04/22/2024$0.49$0.48-0.68%$0.49$0.46450,430 shs$19.29 million04/19/2024$0.49$0.49-0.39%$0.51$0.48530,724 shs$19.42 million04/18/2024$0.47$0.49+3.61%$0.51$0.461.38 million shs$19.50 million04/17/2024$0.49$0.47-3.40%$0.50$0.46610,147 shs$18.82 million04/16/2024$0.49$0.49-0.95%$0.51$0.48317,499 shs$19.48 million04/15/2024$0.51$0.49-3.49%$0.54$0.471.84 million shs$19.67 million04/12/2024$0.50$0.51+3.07%$0.55$0.471.06 million shs$20.38 million04/11/2024$0.47$0.50+5.38%$0.51$0.47776,421 shs$19.77 million04/10/2024$0.47$0.47+1.05%$0.47$0.46592,956 shs$18.76 million04/09/2024$0.47$0.47-1.25%$0.47$0.45461,285 shs$18.57 million04/08/2024$0.48$0.47-1.79%$0.48$0.451.28 million shs$18.80 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$0.49$0.48-2.36%$0.50$0.461.15 million shs$19.15 million04/04/2024$0.50$0.49-1.11%$0.52$0.49444,975 shs$19.61 million04/03/2024$0.53$0.50-5.46%$0.53$0.471.38 million shs$19.83 million04/02/2024$0.56$0.53-6.26%$0.55$0.52601,393 shs$20.97 million04/01/2024$0.53$0.56+6.03%$0.56$0.50672,744 shs$22.38 million03/29/2024$0.53$0.53$0.54$0.51778,922 shs$21.10 million03/28/2024$0.53$0.53-0.94%$0.54$0.51773,520 shs$21.10 million03/27/2024$0.53$0.53+0.47%$0.55$0.482.29 million shs$21.30 million03/26/2024$0.57$0.53-6.17%$0.57$0.53862,070 shs$21.20 million03/25/2024$0.58$0.57-1.67%$0.60$0.561.29 million shs$22.60 million03/22/2024$0.57$0.58+1.43%$0.58$0.54779,460 shs$22.98 million03/21/2024$0.62$0.57-7.92%$0.63$0.551.67 million shs$22.66 million03/20/2024$0.63$0.62-2.05%$0.64$0.60505,074 shs$24.60 million03/19/2024$0.65$0.63-2.65%$0.66$0.571.10 million shs$25.12 million03/18/2024$0.71$0.65-8.37%$0.71$0.641.61 million shs$25.80 million03/15/2024$0.67$0.71+6.00%$0.72$0.66692,971 shs$28.16 million03/14/2024$0.71$0.67-6.07%$0.71$0.66813,871 shs$26.57 million03/13/2024$0.66$0.71+6.93%$0.72$0.662.11 million shs$28.28 million03/12/2024$0.69$0.66-4.64%$0.69$0.651.48 million shs$26.45 million03/11/2024$0.72$0.69-3.25%$0.71$0.643.84 million shs$27.73 million03/08/2024$0.75$0.72-3.65%$0.80$0.712.97 million shs$28.66 million03/07/2024$0.83$0.75-10.25%$0.83$0.734.45 million shs$29.75 million03/06/2024$0.90$0.83-8.02%$0.93$0.832.92 million shs$33.15 million03/05/2024$1.07$0.90-15.24%$1.05$0.896.48 million shs$35.99 million03/04/2024$1.89$1.07-43.65%$1.15$1.0514.20 million shs$42.46 million03/01/2024$1.24$1.89+52.42%$3.31$1.7692.50 million shs$75.35 million02/29/2024$1.25$1.24-0.80%$1.28$1.2092,483 shs$49.44 million Related Companies: Enlivex Therapeutics Stock Chart Aytu BioPharma Stock Chart Vistagen Therapeutics Stock Chart Cyteir Therapeutics Stock Chart Cellectar Biosciences Stock Chart BeyondSpring Stock Chart Clearside Biomedical Stock Chart PMV Pharmaceuticals Stock Chart Verastem Stock Chart LifeVantage Stock Chart Receive BIVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIVI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.